Tackling the two greatest obstacles to Tuberculosis elimination: Treatment of latent infection and drug resistant disease.
Menzies, Richard
4 enregistrements totalisant 14,197,418.00 $ CAN, selon les données ouvertes officielles du gouvernement du Canada.
Intégrer ce graphique
Par ministère
| Instituts de recherche en santé du Canada | $14,197,418 | 4 enregistrements |
Enregistrements
Menzies, Richard
$7,899,734.00
Canadian Institutes of Health Research | Instituts de recherche en santé du Canada
EF 2015-2016
Canada
Menzies, Richard
$4,617,694.00
Canadian Institutes of Health Research | Instituts de recherche en santé du Canada
Research in Priority Areas
EF 2024-2025
Canada
As a component of Canada’s Biomanufacturing and Life Sciences Strategy, this funding opportunity shares the same objectives, namely: • To better prepare Canada to respond to pandemics and other hea...
Menzies, Richard
$1,154,425.00
Canadian Institutes of Health Research | Instituts de recherche en santé du Canada
Research in Priority Areas
EF 2024-2025
Canada
As a component of Canada’s Biomanufacturing and Life Sciences Strategy, this funding opportunity shares the same objectives, namely: • To better prepare Canada to respond to pandemics and other hea...
MENZIES, Richard
$525,565.00
Canadian Institutes of Health Research | Instituts de recherche en santé du Canada
EF 2011-2012
Canada
Evaluation of potential biomarkers of successful treatment of latent tuberculosis